Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Ophthalmology. Retina|May 14, 2019
Vision-Related Quality of Life in Patients with Diabetic Macular Edema Treated with Intravitreal Aflibercept: The AQUA StudyJustus G Garweg, Jana Stefanickova, Carel Hoyng, et al.
Advances in Therapy|April 12, 2022
Dosing Regimens of Intravitreal Aflibercept for Diabetic Macular Edema Beyond the First Year: VIOLET, a Prospective Randomized TrialJustus G Garweg, Jana Štefanickova, Carel Hoyng, et al.
Obstetrics and Gynecology|November 19, 2013
Two low-dose levonorgestrel intrauterine contraceptive systems: a randomized controlled trialAnita Nelson, Dan Apter, Brian Hauck, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|December 9, 2016
Evaluation of a new, low-dose levonorgestrel intrauterine contraceptive system over 5 years of useKristina Gemzell-Danielsson, Dan Apter, Sylvia Dermout, et al.
American Journal of Ophthalmology|February 8, 2021
Efficacy and Safety of Intravitreal Aflibercept Treat-and-Extend for Macular Edema in Central Retinal Vein Occlusion: the CENTERA StudyJean-François Korobelnik, Michael Larsen, Nicole Eter, et al.
Retina (Philadelphia, Pa.)|March 30, 2021
EFFICACY AND SAFETY OF INTRAVITREAL AFLIBERCEPT USING A TREAT-AND-EXTEND REGIMEN FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: The ARIES Study: A Randomized Clinical TrialPaul Mitchell, Frank G Holz, Philip Hykin, et al.
Lung Cancer (Amsterdam, Netherlands)|March 26, 2013
Prospective, multicenter, randomized, independent-group, open-label phase II study to investigate the efficacy and safety of three regimens with two doses of sagopilone as second-line therapy in patients with stage IIIB or IV non-small-cell lung cancerDavid F Heigener, Joachim von Pawel, Corinna Eschbach, et al.
Japanese Journal of Ophthalmology|January 21, 2021
Efficacy and safety of intravitreal aflibercept for polypoidal choroidal vasculopathy: 96-week outcomes in the Japanese subgroup of the PLANET studyYuichiro Ogura, Tomohiro Iida, Won Ki Lee, et al.
Retina (Philadelphia, Pa.)|February 23, 2018
EFFICACY AND SAFETY OUTCOMES OF INTRAVITREAL AFLIBERCEPT FOCUSING ON PATIENTS WITH DIABETIC MACULAR EDEMA FROM JAPANHiroko Terasaki, Kunihiko Shiraki, Masahito Ohji, et al.
Advances in Therapy|January 6, 2024
Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration Beyond One Year of Treatment: AZURE, a Randomized Trial of Treat-and-Extend vs. Fixed DosingLaurent Kodjikian, Lluís Arias Barquet, András Papp, et al.
Pageof 5